Code
|
89027
|
MA number
|
16/0140/06-S
|
Product Form:
|
plv iol 1x250 IU+1x5 ml solv. (liek.inj.skl.+liek.inj.skl.)
|
MA Status:
|
D - Marketing Authorisation valid for an unlimited period
|
Type of procedure:
|
Mutual recognition procedure
|
MAH, country:
|
Baxalta Innovations GmbH, Austria
|
Therapeutic Class:
|
16 - ANTICOAGULANTIA (FIBRINOLYTICA, ANTIFIBRINOL.)
|
ATC:
|
B |
BLOOD AND BLOOD FORMING ORGANS |
B02 |
ANTIHEMORRHAGICS |
B02B |
LOCAL HEMOSTATICS, COMBINATIONS |
B02BD |
Blood coagulation factors |
B02BD06 |
Von Willebrand factor and coagulation factor VIII in combination |
|
Shelf life:
|
24 |
Container:
|
glass vial
|
Route of admin.:
|
Intravenous use
|